Investors Financial Group’s AbbVie ABBV Stock Holding History

Investors Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,291	Closed	-$1.53M	–	2
2021 Q4	$1.53M	Buy	11,291 +392	+4%	+$46.3K	0.71%	31
2021 Q3	$1.18M	Buy	10,899 +1,096	+11%	+$125K	0.62%	38
2021 Q2	$1.1M	Buy	9,803 +220	+2%	+$24.8K	0.59%	43
2021 Q1	$1.04M	Buy	9,583 +2,028	+27%	+$217K	0.61%	43
2020 Q4	$810K	Sell	7,555 -232	-3%	-$22.3K	0.54%	54
2020 Q3	$682K	Buy	7,787 +538	+7%	+$50.7K	0.51%	55
2020 Q2	$712K	Buy	7,249 +3,080	+74%	+$271K	0.59%	49
2020 Q1	$318K	Buy	4,169 +1,751	+72%	+$149K	0.32%	83
2019 Q4	$214K	Buy	+2,418	New	+$201K	0.17%	122

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Investors Financial Group's ABBV Position: Q1 2022 in Review

Investors Financial Group sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 11,291 shares — an estimated $1.53M sold.

Investors Financial Group first reported a position in ABBV in Q4 2019 and held it in 9 quarters. The position peaked at $1.53M in Q4 2021. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Investors Financial Group reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
Investors Financial Group sold 11,291 AbbVie shares in Q1 2022, an estimated $1.53M.
Investors Financial Group first reported a position in AbbVie in Q4 2019 and held it in 9 quarters.
Investors Financial Group's AbbVie position peaked at $1.53M in Q4 2021.
3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.